CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel (CDC)

Manufactured by Centers for Disease Control and Prevention, United States - www.cdc.gov/coronavirus/2019-ncov/lab/testing.html 

Related Scientific Literature

• Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources
• Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape
• Detection of COVID-19: A review of the current literature and future perspectives
• Current and Perspective Diagnostic Techniques for COVID-19
• COVID-19 symptoms predictive of healthcare workers' SARS-CoV-2 PCR results
• Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2
• Assay Techniques and Test Development for COVID-19 Diagnosis.
• Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases
• Rapid detection of novel coronavirus/Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcription-loop-mediated isothermal amplification
• Comparison of abbott id now, diasorin simplexa, and CDC fda emergency use authorization methods for the detection of sars-cov-2 from nasopharyngeal and nasal swabs from individuals diagnosed with covid-19

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements